-
1
-
-
0036803533
-
Depression and public health. An overview
-
Cassano P, Fava M. Depression and public health. An overview. J Psychosom Res 2003; 53: 849-857
-
(2003)
J Psychosom Res
, vol.53
, pp. 849-857
-
-
Cassano, P.1
Fava, M.2
-
3
-
-
19844373148
-
Size and burden of mental disorders in Europe: A critical review and appraisal of 27 studies
-
Wittchen HU, Jacobi F. Size and burden of mental disorders in Europe: a critical review and appraisal of 27 studies. Eur Neuropsychopharmacol 2005; 15: 357-376
-
(2005)
Eur Neuropsychopharmacol
, vol.15
, pp. 357-376
-
-
Wittchen, H.U.1
Jacobi, F.2
-
5
-
-
0024361590
-
The functioning and well-being of depressed patients. Results from the medical outcomes study
-
DOI 10.1001/jama.262.7.914
-
Wells KB, Stewart A, Hays RD, et al. The functioning and well-being of depressed patients: results from the Medical Outcomes Study. JAMA 1989; 262: 914-919 (Pubitemid 19208948)
-
(1989)
Journal of the American Medical Association
, vol.262
, Issue.7
, pp. 914-919
-
-
Wella, K.B.1
Stewart, A.2
Hays, R.D.3
Burnam, M.A.4
Rogers, W.5
Daniels, M.6
Berry, S.7
Greenfield, S.8
Ware, J.9
-
6
-
-
0032853228
-
Functioning and utility for current health of patients with depression or chronic medical conditions in managed, primary care practices
-
Wells KB, Sherbourne CD. Functioning and utility for current health of patients with depression or chronic medical conditions in managed, primary care practices. Arch Gen Psychiatry 1999; 56: 897-904
-
(1999)
Arch Gen Psychiatry
, vol.56
, pp. 897-904
-
-
Wells, K.B.1
Sherbourne, C.D.2
-
7
-
-
0028842902
-
Health-related quality of life in primary care patients with mental disorder: Results from the PRIME-MD Study
-
Spitzer RL, Kroenke K, Linzer M, et al. Health-related quality of life in primary care patients with mental disorder: results from the PRIME-MD Study. JAMA 1995; 274: 1511-1517
-
(1995)
JAMA
, vol.274
, pp. 1511-1517
-
-
Spitzer, R.L.1
Kroenke, K.2
Linzer, M.3
-
8
-
-
0028799794
-
Functioning and well-being outcomes of patients with depression compared with chronic general medical illnesses
-
Hays RD, Wells KB, Sherbourne CD, et al. Functioning and well-being outcomes of patients with depression compared with chronic general medical illnesses. Arch Gen Psychiatry 1995; 52: 11-19
-
(1995)
Arch Gen Psychiatry
, vol.52
, pp. 11-19
-
-
Hays, R.D.1
Wells, K.B.2
Sherbourne, C.D.3
-
9
-
-
0004152029
-
-
Cassano GB, Pancheri P, Pavan L, et al. (eds). Milano: Masson
-
Cassano GB, Pancheri P, Pavan L, et al. (eds). Trattato Italiano di Psichiatria. Milano: Masson, 2002
-
(2002)
Trattato Italiano di Psichiatria
-
-
-
10
-
-
0004235298
-
-
4th edition (DSM-IV). Washington, DC: American Psychiatric Association
-
Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV). Washington, DC: American Psychiatric Association, 1994
-
(1994)
Diagnostic and Statistical Manual of Mental Disorders
-
-
-
11
-
-
0034780546
-
Depressive disorders in Europe: Prevalence figures from the ODIN study
-
Ayuso-Mateos JL, Vazquez-Barquero JL, Dowrick C, et al. Depressive disorders in Europe: prevalence figures from the ODIN study. Br J Psychiatry 2001; 179: 308-316
-
(2001)
Br J Psychiatry
, vol.179
, pp. 308-316
-
-
Ayuso-Mateos, J.L.1
Vazquez-Barquero, J.L.2
Dowrick, C.3
-
12
-
-
0036331407
-
Depression in primary care. A nationwide epidemiological survey
-
Berardi D, Leggieri G, Berti Ceroni G, et al. Depression in primary care. A nationwide epidemiological survey. Fam Pract 2002; 19: 397-400
-
(2002)
Fam Pract
, vol.19
, pp. 397-400
-
-
Berardi, D.1
Leggieri, G.2
Berti Ceroni, G.3
-
13
-
-
0029079345
-
Mechanisms of action of antidepressants
-
Leonard BE. Mechanisms of action of antidepressants. Drugs 1995; 4: 1-12
-
(1995)
Drugs
, vol.4
, pp. 1-12
-
-
Leonard, B.E.1
-
14
-
-
0033002399
-
Mechanism of action of antidepressant medication
-
Feighner JP. Mechanism of action of antidepressant medication. J Clin Psychiatry 1999; 60: 4-11
-
(1999)
J Clin Psychiatry
, vol.60
, pp. 4-11
-
-
Feighner, J.P.1
-
15
-
-
17644423099
-
Prospective, multicentre, randomized, double-blind study of the efficacy of escitalopram versus citalopram in outpatient treatment of major depressive disorder
-
Moore N, Verdoux H, Fantino B. Prospective, multicentre, randomized, double-blind study of the efficacy of escitalopram versus citalopram in outpatient treatment of major depressive disorder. Int Clin Psychopharmacol 2005; 20: 131-137
-
(2005)
Int Clin Psychopharmacol
, vol.20
, pp. 131-137
-
-
Moore, N.1
Verdoux, H.2
Fantino, B.3
-
16
-
-
5444260024
-
A double-blind comparison of escitalopram and venlafaxine extended release in the treatment of major depressive disorder
-
Bielski RJ, Ventura D, Chang CC. A double-blind comparison of escitalopram and venlafaxine extended release in the treatment of major depressive disorder. J Clin Psychiatry 2004; 65: 1190-1196
-
(2004)
J Clin Psychiatry
, vol.65
, pp. 1190-1196
-
-
Bielski, R.J.1
Ventura, D.2
Chang, C.C.3
-
17
-
-
3142756613
-
Escitalopram versus Citalopram: The surprising role of the R-enantiomer
-
Sanchez C, Bogeso KP, Ebert B, et al. Escitalopram versus Citalopram: the surprising role of the R-enantiomer. Psychopharmacology (Berl) 2004; 174: 163-176
-
(2004)
Psychopharmacology (Berl)
, vol.174
, pp. 163-176
-
-
Sanchez, C.1
Bogeso, K.P.2
Ebert, B.3
-
18
-
-
0036080635
-
Efficacy comparison of escitalopram and citalopram in the treatment of major depressive disorder: Pooled analysis of placebo-controlled trials
-
Gorman JM, Korotzer A, Su G. Efficacy comparison of escitalopram and citalopram in the treatment of major depressive disorder: pooled analysis of placebo-controlled trials. CNS Spectr 2002; 7 (4 Suppl. 1): 40-44
-
(2002)
CNS Spectr
, vol.7
, Issue.4 SUPPL. 1
, pp. 40-44
-
-
Gorman, J.M.1
Korotzer, A.2
Su, G.3
-
19
-
-
2342481128
-
Do equivalent doses of escitalopram and citalopram have similar efficacy? A pooled analysis of two positive placebo-controlled studies in major depressive disorder
-
Lepola U, Wade A, Andersen HF. Do equivalent doses of escitalopram and citalopram have similar efficacy? A pooled analysis of two positive placebo-controlled studies in major depressive disorder. Int Clin Psychopharmacol 2004; 19: 149-155
-
(2004)
Int Clin Psychopharmacol
, vol.19
, pp. 149-155
-
-
Lepola, U.1
Wade, A.2
Andersen, H.F.3
-
20
-
-
14844365616
-
Efficacy of escitalopram in patients with severe depression: A pooled analysis
-
Llorca PM, Azorin JM, Despiegel N, et al. Efficacy of escitalopram in patients with severe depression: a pooled analysis. Int J Clin Pract 2005; 59: 268-275
-
(2005)
Int J Clin Pract
, vol.59
, pp. 268-275
-
-
Llorca, P.M.1
Azorin, J.M.2
Despiegel, N.3
-
21
-
-
2642585582
-
A randomised study comparing escitalopram with venlafaxine XR in primary care patients with major depressive disorder
-
Montgomery SA, Huusom AK, Bothmer J. A randomised study comparing escitalopram with venlafaxine XR in primary care patients with major depressive disorder. Neuropsychobiology 2004; 50: 57-64
-
(2004)
Neuropsychobiology
, vol.50
, pp. 57-64
-
-
Montgomery, S.A.1
Huusom, A.K.2
Bothmer, J.3
-
22
-
-
67649231073
-
Differences in the dynamics of serotonin reuptake transporter occupancy may explain superior clinical efficacy of escitalopram versus citalopram
-
Kasper S, Sacher J, Klein N, et al. Differences in the dynamics of serotonin reuptake transporter occupancy may explain superior clinical efficacy of escitalopram versus citalopram. Int Clin Psychopharmacology 2009; 24: 119-125
-
(2009)
Int Clin Psychopharmacology
, vol.24
, pp. 119-125
-
-
Kasper, S.1
Sacher, J.2
Klein, N.3
-
23
-
-
0038441914
-
Escitalopram (10-20 mg/day) is effective and well tolerated in a placebo-controlled study in depression in primary care
-
Lepola UM, Loft H, Reines EH. Escitalopram (10-20 mg/day) is effective and well tolerated in a placebo-controlled study in depression in primary care. Int Clin Psychopharmacol 2003; 18: 211-217
-
(2003)
Int Clin Psychopharmacol
, vol.18
, pp. 211-217
-
-
Lepola, U.M.1
Loft, H.2
Reines, E.H.3
-
24
-
-
37349069949
-
Efficacy and tolerability of escitalopram versus citalopram in major depressive disorder: A six-week, multicenter, prospective, randomized, double-blind, active-controlled study in adult outpatients
-
Yevtushenko VY, Belous AI, Yevtushenko YG, et al. Efficacy and tolerability of escitalopram versus citalopram in major depressive disorder: a six-week, multicenter, prospective, randomized, double-blind, active-controlled study in adult outpatients. Clin Ther 2007; 29: 2319-2332
-
(2007)
Clin Ther
, vol.29
, pp. 2319-2332
-
-
Yevtushenko, V.Y.1
Belous, A.I.2
Yevtushenko, Y.G.3
-
25
-
-
77952917829
-
-
L'uso dei farmaci in Italia. Rapporto Osmed, Data ultimo accesso Settembre
-
L'uso dei farmaci in Italia. Rapporto Osmed 2005. http://www. agenziafarmaco.it/ATTIVITA-EDITORIALE/gotopage-section3894.html. Data ultimo accesso Settembre 2009
-
(2005)
-
-
-
26
-
-
0141998510
-
Prevalence estimates of chronic diseases in Italy: Exploring the differences between self-report and primary care databases
-
Cricelli C, Mazzaglia G, Samani F, et al. Prevalence estimates of chronic diseases in Italy: exploring the differences between self-report and primary care databases. J Public Health Med 2003; 25: 254-257
-
(2003)
J Public Health Med
, vol.25
, pp. 254-257
-
-
Cricelli, C.1
Mazzaglia, G.2
Samani, F.3
-
27
-
-
77952906210
-
Use of computerized general practice database for epidemiological studies in Italy: A comparative study with the official national statistics
-
Mazzaglia G, Sessa E, Samani F, et al. Use of computerized general practice database for epidemiological studies in Italy: a comparative study with the official national statistics. J Epidemiol Commun Health 2004; 58 (Suppl. 1): A133
-
(2004)
J Epidemiol Commun Health
, vol.58
, Issue.SUPPL. 1
-
-
Mazzaglia, G.1
Sessa, E.2
Samani, F.3
-
28
-
-
0037383191
-
Secondary prevention of stroke in Italy: A cross-sectional survey in family practice
-
Filippi A, Bignamini AA, Sessa E, et al. Secondary prevention of stroke in Italy: a cross-sectional survey in family practice. Stroke 2003; 34: 1010-1014
-
(2003)
Stroke
, vol.34
, pp. 1010-1014
-
-
Filippi, A.1
Bignamini, A.A.2
Sessa, E.3
-
29
-
-
0042669800
-
Effects of an automated electronic reminder in changing prescribing behaviour among General Practitioners in Italy: An intervention trial
-
Filippi A, Sabatini A, Badioli L, et al. Effects of an automated electronic reminder in changing prescribing behaviour among General Practitioners in Italy: an intervention trial. Diabetes Care 2003; 26: 1497-1500
-
(2003)
Diabetes Care
, vol.26
, pp. 1497-1500
-
-
Filippi, A.1
Sabatini, A.2
Badioli, L.3
-
30
-
-
29244462820
-
Patterns of persistence with antihypertensive medications in newly diagnosed hypertensive patients in Italy: A retrospective cohort study in primary care
-
Mazzaglia G, Mantovani LG, Sturkenboom MC, et al. Patterns of persistence with antihypertensive medications in newly diagnosed hypertensive patients in Italy: a retrospective cohort study in primary care. J Hypertens 2005; 23: 2093-2100
-
(2005)
J Hypertens
, vol.23
, pp. 2093-2100
-
-
Mazzaglia, G.1
Mantovani, L.G.2
Sturkenboom, M.C.3
-
31
-
-
0037237709
-
Realta prescrittiva versus standard di consumo nel campo degli inibitori della pompa protonica in Italia
-
Lucioni C, Mazzi S. Realta prescrittiva versus standard di consumo nel campo degli inibitori della pompa protonica in Italia. PharmacoEconomics-Italian Research Articles 2003; 5: 3-10
-
(2003)
PharmacoEconomics-Italian Research Articles
, vol.5
, pp. 3-10
-
-
Lucioni, C.1
Mazzi, S.2
-
32
-
-
33751361471
-
Resource allocation to brain research in Europe (RABRE)
-
Sobocki P, Lekander I, Berwick S, et al. Resource allocation to brain research in Europe (RABRE). Eur J Neurosci 2006; 24: 2691-2693
-
(2006)
Eur J Neurosci
, vol.24
, pp. 2691-2693
-
-
Sobocki, P.1
Lekander, I.2
Berwick, S.3
-
33
-
-
0346622392
-
Cost of depression among adults in England in 2000
-
Thomas CM, Morris S. Cost of depression among adults in England in 2000. Br J Psychiatry 2003; 183: 514-519
-
(2003)
Br J Psychiatry
, vol.183
, pp. 514-519
-
-
Thomas, C.M.1
Morris, S.2
-
34
-
-
64849100165
-
Results of a retrospective claims database analysis of differences in antidepressant treatment persistence associated with escitalopram and other selective serotonin reuptake inhibitors in the United States
-
Esposito D, Wahl P, Daniel G, et al. Results of a retrospective claims database analysis of differences in antidepressant treatment persistence associated with escitalopram and other selective serotonin reuptake inhibitors in the United States. Clin Ther 2009; 31: 644-656
-
(2009)
Clin Ther
, vol.31
, pp. 644-656
-
-
Esposito, D.1
Wahl, P.2
Daniel, G.3
-
35
-
-
67749119872
-
Treatment persistence, healthcare utilisation and costs in adult patients with major depressive disorder: A comparison between escitalopram and other SSRI/SNRIs
-
Wu EQ, Greenberg PE, Yang E, et al. Treatment persistence, healthcare utilisation and costs in adult patients with major depressive disorder: a comparison between escitalopram and other SSRI/SNRIs. J Med Econ 2009; 12: 124-135
-
(2009)
J Med Econ
, vol.12
, pp. 124-135
-
-
Wu, E.Q.1
Greenberg, P.E.2
Yang, E.3
|